These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19465782)

  • 21. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Wachtell K; Ibsen H; Olsen MH; Borch-Johnsen K; Lindholm LH; Mogensen CE; Dahlöf B; Devereux RB; Beevers G; de Faire U; Fyhrquist F; Julius S; Kjeldsen SE; Kristianson K; Lederballe-Pedersen O; Nieminen MS; Okin PM; Omvik P; Oparil S; Wedel H; Snapinn SM; Aurup P
    Ann Intern Med; 2003 Dec; 139(11):901-6. PubMed ID: 14644892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of coronary reserve in patients with hypertensive disease and without hypertrophy left ventricular].
    Iskenderov BG; Shibaeva TM; Minkin AA; Bogdanova SR
    Kardiologiia; 2005; 45(3):10-3. PubMed ID: 15821701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE; Cramariuc D; Boman K; Gohlke-Bärwolf C; Staal EM; Lønnebakken MT; Rossebø AB; Gerdts E
    Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G
    Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Left ventricular hypertrophy in hypertension].
    Ghanem Wisam MA; Murin J; Bulas J; Kozlikova K; Jaber J; Radman A
    Bratisl Lek Listy; 2000; 101(8):455-9. PubMed ID: 11153171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
    de Simone G; Izzo R; Losi MA; Stabile E; Rozza F; Canciello G; Mancusi C; Trimarco V; De Luca N; Trimarco B
    J Hypertens; 2016 Sep; 34(9):1846-53. PubMed ID: 27367264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reality and enigmas in left ventricular hypertrophy in arterial hypertension].
    González-Juanatey JR
    Med Clin (Barc); 1992 Nov; 99(17):656-8. PubMed ID: 1447937
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute ischemia in myocardial hypertrophy: a report of 2 clinical cases].
    Dodi C; Lazzeroni E; Iori E; Bruno G
    G Ital Cardiol; 1995 Mar; 25(3):345-51. PubMed ID: 7642041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease.
    Zehender M; Faber T; Koscheck U; Meinertz T; Just H
    Clin Cardiol; 1995 Jul; 18(7):377-83. PubMed ID: 7554542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and silent myocardial ischemia: their influence on cardiovascular mortality and morbidity.
    Hedblad B; Janzon L
    Cardiology; 1994; 85 Suppl 2():16-23. PubMed ID: 7736483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
    Gerdts E; Wachtell K; Omvik P; Otterstad JE; Oikarinen L; Boman K; Dahlöf B; Devereux RB
    Hypertension; 2007 Feb; 49(2):311-6. PubMed ID: 17178978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
    Olsen MH; Wachtell K; Bella JN; Gerdts E; Palmieri V; Nieminen MS; Smith G; Ibsen H; Devereux RB;
    Am J Cardiol; 2005 Jan; 95(1):132-6. PubMed ID: 15619412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular morbidity and mortality and electrocardiographic criteria of left ventricular hypertrophy in hypertensive patients treated in primary care].
    Tovillas-Morán FJ; Vilaplana-Cosculluela M; Zabaleta-del-Olmo E; Dalfó-Baqué A; Galcerán JM; Coca A
    Med Clin (Barc); 2010 Sep; 135(9):397-401. PubMed ID: 20816389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summaries for patients. Microalbuminuria increases risk for heart attacks and strokes in hypertensive patients.
    Ann Intern Med; 2003 Dec; 139(11):I26. PubMed ID: 14644907
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the relation between hypertensive left ventricular hypertrophy in very old people with neurohormonal factors and ventricular arrhythmias].
    Guo H; Lu D; Wang J; He H; Zhou B; Jiang C
    Zhonghua Nei Ke Za Zhi; 2000 Dec; 39(12):825-7. PubMed ID: 11798545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?
    Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Imai M; Kiyomoto H; Nishiyama A; Kohno M
    Clin Exp Hypertens; 2010 Jan; 32(2):113-20. PubMed ID: 20374184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.